Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Ullrich, Munzel"'
Autor:
Ullrich Munzel, Eli O. Meltzer, Cathryn A. Carroll, Brian J. Lipworth, Kellie Morland, Diana Brixner
Publikováno v:
International Journal of Technology Assessment in Health Care. 32:371-375
Objectives: Various minimal clinically important difference (MCID) threshold estimation techniques have been applied to seasonal allergic rhinitis (SAR). The objectives of this study are to (i) assess the difference in magnitude of alternative SAR MC
Autor:
David Price, Ferdinand Kopietz, Arkady Koltun, Hans Christian Kuhl, Ullrich Munzel, Anne Marie Salapatek, Jean Bousquet, Duc Tung Nguyen, Peter Couroux, Eli O. Meltzer
Publikováno v:
Journal of Allergy and Clinical Immunology: In Practice
Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2018, 6 (5), pp.1726-1732.e6. ⟨10.1016/j.jaip.2018.01.031⟩
Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2018, 6 (5), pp.1726-1732.e6. ⟨10.1016/j.jaip.2018.01.031⟩
International audience; BACKGROUND:A fixed-dose combination of intranasal azelastine hydrochloride and fluticasone propionate (MP-AzeFlu) is the most effective treatment of allergic rhinitis, but its onset of action requires further investigation.OBJ
Autor:
Ralph Mösges, Ullrich Munzel, Ulrich Wahn, Jean Bousquet, Ludger Klimek, David Price, Claus Bachert, J. Christian Virchow
Publikováno v:
Allergy and Asthma Proceedings. 36:40-47
The efficacy of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) has been well established in controlled clinical trials. This study was designed to assess the use of MP29-
Autor:
Phil Lieberman, Sanjay Bhatia, Shailen Shah, William E. Berger, David Price, James A. Hadley, Ullrich Munzel
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 2:179-185
Background MP29-02 is a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate (FP) in an advanced delivery system for the treatment of seasonal allergic rhinitis. Objective The objective of this study was to evaluate the
Autor:
W. Carr, Frank C. Hampel, Joaquim Mullol, Phil Lieberman, Glenis Scadding, Ruth Murray, Claus Bachert, James A. Hadley, Paul H. Ratner, Jean Bousquet, Ulrich Wahn, William E. Berger, G. Walter Canonica, Eli O. Meltzer, David Price, Ullrich Munzel, J. Christian Virchow
Publikováno v:
International Archives of Allergy and Immunology. 161:369-377
Background: It is unclear what constitutes a clinically meaningful response for allergic rhinitis (AR) outcomes. The objectives of these post hoc analyses were (1) to define a clinically meaningful response using novel efficacy analyses (including a
Autor:
Ullrich Munzel, Jean Bousquet, Joachim Maus, Robert Hermann, Hermann Mascher, Hartmut Derendorf, Ursula Petzold
Publikováno v:
British Journal of Clinical Pharmacology. 74:125-133
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • The topical second generation anti-histamine azelastine hydrochloride (AZE) and the potent corticosteroid fluticasone propionate (FP) are well established first-line treatments in allergic rhinitis (AR).
Publikováno v:
Arzneimittelforschung. 58:168-173
The objective of this post-marketing surveillance (PMS) was the evaluation of efficacy, tolerability, and acceptance of the advanced formoterol (CAS 73573-87-2) multidose dry powder inhaler (MDPI) Formatris 6 microg/12 microg Novolizer (FN) in asthma
Autor:
Hans J. Tritschler, Andrew J.M. Boulton, William J. Litchy, Phillip A. Low, Peter J. Dyck, Rustem Samigullin, Dan Ziegler, Ullrich Munzel, Roy Freeman, Aaron I. Vinik, Joachim Maus, Klemens Schütte
Publikováno v:
Diabetes Care. 34:2054-2060
OBJECTIVE To evaluate the efficacy and safety of α-lipoic acid (ALA) over 4 years in mild-to-moderate diabetic distal symmetric sensorimotor polyneuropathy (DSPN). RESEARCH DESIGN AND METHODS In a multicenter randomized double-blind parallel-group t
Autor:
David Price, Ferdinand Kopietz, Ullrich Munzel, Arkady Koltun, Jean Bousquet, Hans-Christian Kuhl, Duc Tung Nguyen, Eli O. Meltzer
Publikováno v:
Journal of Allergy and Clinical Immunology. 141:AB404
Autor:
H. Kuhl, David Price, Ullrich Munzel, Eli O. Meltzer, A. Koltun, D. Nguyen, F. Kopietz, Jean Bousquet
Publikováno v:
Annals of Allergy, Asthma & Immunology. 119:e2